Torrent Pharmaceuticals Ltd. · Q3FY26
Result on 13 Feb 2026, first traded on 16 Feb 2026; judged on 15 Sep 2026. The last read before it, on 7 Feb 2026 (6 days ahead), called it favourable, rank 76 of 367 reporting; the share then beat the market over ten sessions. The company's page →
read rightverdict
favourablethe read
+9.5%vs market, 10 sessions
+4.4%T+1
1 · What the read said
morning of 7 Feb- Read
- favourable — rank 76 of 367 reporting that week
- Composite
- 67.1 out of 100
- Evidence
- full · 13 results on record
- Expected move
- ±2.5% on the day — its average absolute move on results
- Habit
- continuation — the day-one move usually carries on over the following sessions
- Close that morning
- ₹3,939.00
Reactivity · 30%
16
Momentum · 20%
100
vs market · 30%
78
vs sector · 20%
95
Each layer is a percentile among that week's reporters (0–100). A missing layer's weight is spread over the others.
Composite = 0.30 × 15.5 + 0.20 × 100.0 + 0.30 × 78.1 + 0.20 × 95.2 = 67.1
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹4,078.00the base every move below is measured from
T+1+4.4%a real move — at least 60% of its usual
T+10+7.1%market -2.4% · sector +3.4%
vs market+9.5%vs sector +3.7%
Best close after+8.4%traded as high as +9.6% on 26 Feb
Worst close after+3.3%traded as low as +1.0% on 16 Feb
Run-up, 30 sessions+6.0%into the result
52-week range0% below high39% above low
- Delivery share
- +1.2 points in the fortnight before, against the month before that
- Volume
- 1.30× its prior month, in the fortnight before
- Habit held
- continuation — held this quarter
- Announced
- Mon, timing unknown
- Peers reporting
- 8 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- Its continuation habit held this quarter.
- 8 sector peers reported the same week; the sector read may already have been set.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
1 mornings| Morning | Days ahead | Read | Rank | Comp. | L1 | L2 | L3 | L4 | Close | Note |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Feb judged simulated | 6 | favourable | 76/367 | 67.1 | 16 | 100 | 78 | 95 | ₹3,939.00 |
A read is made each morning the company is due within seven days. The highlighted morning is the last one before the result — the read this post-mortem judges. Excluded mornings show why the name dropped out that day.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base | NIFTY PHARMA from base |
|---|---|---|---|---|---|---|---|---|---|
| T-28 | 2 Jan | 3,856.70 | 3,891.20 | 3,821.00 | 3,885.30 | — | -4.73% | +3.37% | +2.69% |
| T-27 | 5 Jan | 3,885.30 | 3,900.10 | 3,855.00 | 3,869.80 | -0.40% | -5.11% | +3.06% | +2.47% |
| T-26 | 6 Jan | 3,879.80 | 3,948.00 | 3,859.80 | 3,936.80 | +1.73% | -3.46% | +2.78% | +4.20% |
| T-25 | 7 Jan | 3,936.80 | 4,104.80 | 3,936.00 | 4,092.20 | +3.95% | +0.35% | +2.63% | +4.92% |
| T-24 | 8 Jan | 4,080.00 | 4,080.00 | 4,015.70 | 4,026.40 | -1.61% | -1.27% | +1.59% | +3.46% |
| T-23 | 9 Jan | 4,016.00 | 4,037.60 | 3,950.00 | 3,963.40 | -1.56% | -2.81% | +0.83% | +2.55% |
| T-22 | 12 Jan | 3,960.00 | 3,967.70 | 3,893.80 | 3,949.80 | -0.34% | -3.14% | +1.25% | +2.13% |
| T-21 | 13 Jan | 3,940.00 | 3,959.90 | 3,903.70 | 3,940.30 | -0.24% | -3.38% | +1.03% | +1.66% |
| T-20 | 14 Jan | 3,940.30 | 4,012.90 | 3,906.40 | 4,003.70 | +1.61% | -1.82% | +0.76% | +1.40% |
| T-19 | 16 Jan | 4,020.00 | 4,032.00 | 3,972.00 | 4,018.20 | +0.36% | -1.47% | +0.88% | +0.10% |
| T-18 | 19 Jan | 4,033.30 | 4,107.20 | 4,002.00 | 4,086.60 | +1.70% | +0.21% | +0.45% | -0.26% |
| T-17 | 20 Jan | 4,105.00 | 4,105.00 | 3,962.00 | 3,976.80 | -2.69% | -2.48% | -0.94% | -2.17% |
| T-16 | 21 Jan | 3,960.00 | 4,030.00 | 3,936.90 | 3,981.80 | +0.13% | -2.36% | -1.23% | -2.75% |
| T-15 | 22 Jan | 3,982.50 | 4,032.10 | 3,964.40 | 4,020.50 | +0.97% | -1.41% | -0.71% | -1.20% |
| T-14 | 23 Jan | 4,021.00 | 4,037.60 | 3,903.70 | 3,932.20 | -2.20% | -3.58% | -1.66% | -2.13% |
| T-13 | 27 Jan | 3,968.00 | 4,012.90 | 3,910.40 | 3,997.40 | +1.66% | -1.98% | -1.16% | -1.83% |
| T-12 | 28 Jan | 3,944.60 | 4,013.10 | 3,922.50 | 3,958.70 | -0.97% | -2.93% | -0.50% | -2.05% |
| T-11 | 29 Jan | 3,936.00 | 3,970.20 | 3,900.00 | 3,930.10 | -0.72% | -3.63% | -0.20% | -2.84% |
| T-10 | 30 Jan | 3,920.00 | 4,008.90 | 3,695.00 | 3,960.80 | +0.78% | -2.87% | -0.59% | -2.16% |
| T-9 | 2 Feb | 4,018.50 | 4,018.50 | 3,903.90 | 3,987.20 | +0.67% | -2.23% | -1.50% | -2.91% |
| T-8 | 3 Feb | 4,039.90 | 4,104.10 | 4,010.20 | 4,045.60 | +1.46% | -0.79% | +1.01% | +0.02% |
| T-7 | 4 Feb | 4,066.00 | 4,068.10 | 3,986.70 | 4,023.50 | -0.55% | -1.34% | +1.20% | -0.31% |
| T-6 | 5 Feb | 4,029.90 | 4,029.90 | 3,931.80 | 3,976.40 | -1.17% | -2.49% | +0.67% | -0.34% |
| T-5 | 6 Feb | 3,963.10 | 3,963.10 | 3,908.80 | 3,939.00 | -0.94% | -3.41% | +0.87% | -1.05% |
| T-4 | 9 Feb | 3,968.50 | 4,018.70 | 3,936.20 | 3,997.20 | +1.48% | -1.98% | +1.56% | +0.43% |
| T-3 | 10 Feb | 4,009.00 | 4,085.00 | 4,008.20 | 4,079.60 | +2.06% | +0.04% | +1.82% | +0.07% |
| T-2 | 11 Feb | 4,085.00 | 4,092.90 | 4,041.00 | 4,056.70 | -0.56% | -0.52% | +1.90% | +1.08% |
| T-1 | 12 Feb | 4,056.70 | 4,098.90 | 4,027.00 | 4,077.20 | +0.51% | -0.02% | +1.32% | +0.86% |
| base | 13 Feb | 4,077.20 | 4,130.00 | 4,057.30 | 4,078.00 | +0.02% | +0.00% | +0.00% | +0.00% |
| T+1 | 16 Feb result | 4,144.30 | 4,324.90 | 4,118.00 | 4,261.50 | +4.50% | +4.50% | +0.83% | +0.94% |
| T+2 | 17 Feb | 4,271.50 | 4,276.10 | 4,218.50 | 4,258.40 | -0.07% | +4.42% | +1.00% | +1.35% |
| T+3 | 18 Feb | 4,258.40 | 4,269.90 | 4,186.60 | 4,210.80 | -1.12% | +3.26% | +1.37% | +1.56% |
| T+4 | 19 Feb | 4,238.70 | 4,280.70 | 4,205.00 | 4,226.40 | +0.37% | +3.64% | -0.07% | +1.06% |
| T+5 | 20 Feb | 4,224.10 | 4,250.40 | 4,175.50 | 4,241.70 | +0.36% | +4.01% | +0.39% | +1.16% |
| T+6 | 23 Feb | 4,276.10 | 4,325.00 | 4,244.00 | 4,307.60 | +1.55% | +5.63% | +0.95% | +1.73% |
| T+7 | 24 Feb | 4,307.00 | 4,423.00 | 4,281.50 | 4,397.90 | +2.10% | +7.84% | -0.18% | +1.97% |
| T+8 | 25 Feb | 4,420.00 | 4,443.50 | 4,358.00 | 4,418.90 | +0.48% | +8.36% | +0.04% | +3.86% |
| T+9 | 26 Feb | 4,418.90 | 4,470.00 | 4,389.20 | 4,399.80 | -0.43% | +7.89% | +0.10% | +4.99% |
| T+10 | 27 Feb | 4,420.30 | 4,425.00 | 4,322.70 | 4,333.30 | -1.51% | +6.26% | -1.15% | +3.41% |
| T+11 | 2 Mar | 4,191.00 | 4,397.50 | 4,175.20 | 4,369.20 | +0.83% | +7.14% | -2.38% | +3.43% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.